News

November 23, 2016

Psychological Needs of Mesothelioma Patients Different from Those with Lung Cancer, Study Finds

News

Patients with malignant pleural mesothelioma (MPM) may need different psychological care than patients with advanced lung cancer, according to a recent study published in the European Journal of Oncology Nursing. ... Read more

November 22, 2016November 22, 2016

Clinical Trials of Cancer Vaccine Using Listeria Again Enrolling Patients After FDA Lifts Hold

News

The U.S. Food and Drug Administration (FDA) has lifted a partial hold placed on all Aduro’s clinical trials evaluating the LADD technology platform, a new Listeria-based cancer vaccine. These studies, including one in ... Read more

November 21, 2016

Review Calls for Personalized Approach to Mesothelioma Treatment Development

News

Specific genetic markers need to be identified to allow for personalized treatment of malignant mesothelioma that can be applied once first-line therapy fails, according to a review exploring why newly ... Read more

November 18, 2016

Treatment Trio for Mesothelioma Is Safe, Improves Patients’ Survival Rates, According to Trial Data

News

Combining Tumor Treating Fields (TTFields), a method that uses electric fields to disrupt cell division, with standard chemotherapy treatments Alimta (pemetrexed) and Platinol (cisplatin) or Paraplatin (carboplatin) may be a ... Read more

November 17, 2016

One Week After Colorado, D.C. Council Passes Death with Dignity Act

News

The District of Columbia is taking steps to become the third diversely populated U.S. jurisdiction, and the seventh jurisdiction in the U.S., to authorize medical aid in dying for terminally ill patients. ... Read more

November 16, 2016November 16, 2016

New Tool Seen to Distinguish Malignant Pleural Mesothelioma from Benign Disease

News

Researchers have developed a new tool to diagnose malignant pleural mesothelioma (MPM) that combines differences seen in gene expression — which may also serve as disease biomarkers — with a computational algorithm, according ... Read more

November 15, 2016

Aduro Presents Positive Early Data from Phase 1b Mesothelioma Trial Evaluating Combo Treatment

News

Combining the cancer vaccine CRS-207 with standard of care chemotherapy and cyclophosphamide looks like a promising first-line treatment for patients with unresectable malignant pleural mesothelioma, according to preliminary data from the second cohort of ... Read more

November 14, 2016

Chemotherapy as Add-on to Surgery Gives Mesothelioma Patients Extra Time, Study Shows

News

Chemotherapy in addition to surgery buys malignant mesothelioma patients extra time, and multimodal treatment increases survival even more. These benefits are independent of the surgical method used, suggesting that multiple ... Read more

November 11, 2016November 11, 2016

Targovax Granted European Patent for Vaccine to Treat Mesothelioma, Now in Clinical Trial

News

Targovax has been granted a European patent for its lead product ONCOS-102, a cancer vaccine that is being clinically evaluated in mesothelioma, with tests planned for other solid tumors. The composition of matter patent, ... Read more

November 10, 2016

Different Types of Mesothelioma Show Distinct Frequencies of Gene Mutations, Study Finds

News

Different types of malignant mesothelioma (MM) may be associated with different frequencies of gene mutations, according to a new study published in the journal Modern Pathology. In the study, “Genomic ... Read more